When reviewing a prescription for a C-II substance, which information is NOT required?

In the context of reviewing a prescription for a controlled substance, particularly a Schedule II (C-II) medication, certain pieces of information are critical for ensuring proper dispensing and legal compliance. The National Drug Code (NDC) number, while important for identifying specific medications and their formulations, is not a required element on a prescription for C-II substances.

The Drug Enforcement Administration (DEA) number is essential because it verifies that the prescriber is authorized to prescribe controlled substances. The patient’s street address is needed to confirm their identity and to ensure the prescription is issued correctly. Additionally, “Dispense as Written” (DAW) information is also important, particularly for insurance processing and to ensure that any substitutions are appropriately noted.

Thus, while the NDC number can be useful for tracking and inventory purposes within the pharmacy, it does not need to be included on the actual prescription for a C-II substance. This highlights the specific regulatory focus on validating the legitimacy of the prescriber and the patient rather than on the specific identifying code for the drug itself.